Mice with a genetic deletion in FcγRIV (FcγRIV−/−) showed that therapeutic ability of hIgG1-TA99 in the B16F10-gp75 melanoma model was abolished with no further enhancement of afucosylation. This evidence concerns the gene TYRP1 and melanoma.